News ArticleAnthem Biosciences to Participate in JM Financial India Xchange 2026 Analyst Meetings in Mumbai
Company confirms no unpublished price sensitive information will be shared during the November 16-18, 2026 meetings
Anthem Biosciences Limited has announced its participation in the JM Financial India Xchange 2026 through group and one-on-one analyst and institutional investor meetings scheduled from November 16 to November 18, 2026, in Mumbai. The company confirmed no unpublished price sensitive information will be shared during these meetings.
Anthem Biosciences Limited
Investor Presentation
Anthem Biosciences Limited announced its scheduled participation in the JM Financial India Xchange 2026, featuring group and one-on-one meetings with analysts and institutional investors from November 16 to 18, 2026, in Mumbai.
The meetings will be physical events held in Mumbai, providing an opportunity for direct engagement with key financial stakeholders.
The company emphasized that no unpublished price sensitive information will be disclosed during these interactions, adhering to regulatory compliance.
This announcement was made to comply with Regulation 30 and Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Highlights
- Participation dates: November 16-18, 2026
- Event: JM Financial India Xchange 2026
- Meeting formats: Group and One-on-One
- Location: Mumbai
- Compliance: No unpublished price sensitive information to be shared
- Regulatory basis: SEBI Listing Regulations
Key Data Snapshot
What happened
- Anthem Biosciences Limited will participate in group and one-on-one analyst/institutional investor meetings organized by JM Financial India Xchange 2026.
- The meetings are scheduled for November 16-18, 2026, in Mumbai.
- The company stated that no unpublished price sensitive information will be disclosed during these meetings.
Regulatory and governance context
- The filing is made under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- The announcement ensures compliance with ongoing disclosure obligations for listed companies.
Highlights
- Participation dates: November 16-18, 2026
- Event: JM Financial India Xchange 2026
- Meeting formats: Group and One-on-One
- Location: Mumbai
- Compliance: No unpublished price sensitive information to be shared
- Regulatory basis: SEBI Listing Regulations
Disclosures
- Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 30 and Schedule III
More News on Investor Presentation
View allLatest corporate announcements and market updates in Investor Presentation.
Berger Paints India Achieves 11.9% Standalone Revenue Growth in Q2 FY27 Amid Raw Material Cost Pressures
Berger Paints India Limited recorded an 11.9% standalone revenue increase in the quarter ended 30 September 2026, with consolidated PBDIT rising 5.2%. The Decorative segment showed near double-digit value growth, while margins were pressured by raw material inflation and pricing delays.
Read Full Story
Uno Minda Limited Posts 38% Revenue Growth and Rs 420 Cr PAT in Q2 FY27
Uno Minda Limited announced a 38% year-on-year increase in consolidated revenues to Rs 6,655 crore and a 38% rise in profit after tax to Rs 420 crore for Q2 FY27 in its investor presentation dated November 5, 2026.
Read Full Story
NHPC Approves Unaudited Standalone and Consolidated Financial Results for Q2 Ending September 30, 2026
NHPC Limited's Board of Directors approved the unaudited standalone and consolidated financial results for the quarter ended September 30, 2026. The company has uploaded an investor presentation on its website detailing the financial outcomes for this period.
Read Full Story
